CapEdge
Loading...
Advanced
What's new? Log in Free sign up
  • Home
  • Sectors & IndustriesSectors
  • Earnings
  • IPOs
  • SPACs
  • Transcripts
  • Insider
  • Institutional
  • Crypto
  • Screeners
  • Reddit
  • Splits
  • ALC Dashboard
  • Financials
  • Filings
  • Transcripts
  • ETFs
  • Institutional
  • Shorts
  • News
  • Patents
  • Reddit

Alcon Inc. - Registered Shares (ALC)

Company Profile
Alcon is an American Swiss medical company specializing in eye care products with headquarters in Geneva, Switzerland, and incorporated in Fribourg, Switzerland.
Alcon Inc. - Registered Shares logo

Company profile

Ticker
ALC
Exchange
NYSE
Website
www.alcon.com/
CEO
David Endicott
Employees
Incorporated
Switzerland
Location
Texas
Fiscal year end
Dec 31
Sector
Manufacturing > Surgical and Medical Instrument Manufacturing
Industry (SIC)
Ophthalmic Goods
Bausch + Lomb • National Vision • Warby Parker • RxSight • Cooper Companies • Staar Surgical • Innovative Eyewear • Luxottica Group Spa ...
SEC CIK
0001167379
Corporate docs
Articles of Incorporation & Bylaws
Underwriting Agreements
Plans of Reorganization
Indentures
Material Contracts & Credit Agreements
Subsidiaries Lists

ALC stock data

Analyst ratings and price targets

Last 3 months
Current price
Average target
$77.50
Low target
$69.00
High target
$85.00
Mizuho
Initiated
Buy
$85.00
22 Dec 22
BTIG
Maintains
Buy
$78.00
21 Dec 22
Morgan Stanley
Maintains
Equal-Weight
$78.00
17 Nov 22
Citigroup
Maintains
Neutral
$69.00
17 Nov 22
Latest filings (excl ownership)
View all
6-K
Alcon Reports Third Quarter 2022 Results
15 Nov 22
DEFA14A
Additional proxy soliciting materials
22 Aug 22
6-K
Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio
22 Aug 22
6-K
Alcon Reports Second Quarter 2022 Results
9 Aug 22
SD
Conflict minerals disclosure
26 May 22
6-K
Alcon Reports First Quarter 2022 Results
10 May 22
6-K
Alcon Publishes Agenda for 2022 Annual General Meeting
24 Mar 22
6-K
Current report (foreign)
15 Feb 22
20-F
2021 FY
Annual report (foreign)
15 Feb 22
6-K
Alcon Reports Fourth Quarter and Full Year 2021 Results
15 Feb 22
Transcripts
View all
ALC
Earnings call transcript
2022 Q3
16 Nov 22
ALC
Earnings call transcript
2022 Q2
10 Aug 22
ALC
Earnings call transcript
2022 Q1
11 May 22
ALC
Earnings call transcript
2021 Q2
18 Aug 21
ALC
Earnings call transcript
2021 Q1
5 May 21
ALC
Earnings call transcript
2020 Q4
24 Feb 21
ALC
Earnings call transcript
2020 Q3
11 Nov 20
Latest ownership filings
View all
SC 13G
BlackRock Inc.
8 Sep 22
SC 13G/A
WCM INVESTMENT MANAGEMENT, LLC
10 Feb 22
SC 13G/A
Capital Research Global Investors
16 Feb 21
SC 13G/A
PRICE T ROWE ASSOCIATES INC /MD/
16 Feb 21
SC 13G/A
PRICE T ROWE ASSOCIATES INC /MD/
10 Sep 20
SC 13G
Beneficial ownership report
14 Feb 20
SC 13G
Alcon Inc
10 Jan 20
SC 13D/A
NOVARTIS AG
25 Mar 11
SC 13D/A
NOVARTIS AG
15 Mar 11
SC 13D/A
NOVARTIS AG
1 Mar 11

Financial summary

Financial statements Chart ALC financial data
Quarter (USD) Dec 21 Dec 20 Dec 19 Mar 11
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Mar 11
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Financial data from company earnings reports.

Institutional ownership, Q3 2022

ALC institutional ownership history Ownership history
43.0% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 527 579 -9.0%
Opened positions 42 67 -37.3%
Closed positions 94 64 +46.9%
Increased positions 159 182 -12.6%
Reduced positions 210 199 +5.5%
13F shares Current Prev Q Change
Total value 13.07 bn 15.59 bn -16.1%
Total shares 214.92 mm 223.41 mm -3.8%
Total puts 1.33 mm 958.45 k +38.7%
Total calls 1.59 mm 1.33 mm +19.6%
Total put/call ratio 0.8 0.7 +16.0%
Largest owners Shares Value Change
Vanguard 16.19 mm $941.92 mm +2.3%
Aristotle Capital Management 14.39 mm $837.21 mm -1.6%
Credit Suisse 12.98 mm $755.17 mm +0.0%
Clearbridge Advisors 11.48 mm $668.02 mm -1.7%
Harding Loevner 10.13 mm $589.23 mm -3.3%
Zurcher Kantonalbank 6.89 mm $407.01 mm +13.0%
T. Rowe Price Investment Management 6.35 mm $369.51 mm NEW
Brown Brothers Harriman & Co 5.75 mm $334.61 mm +4.1%
Ako Capital 5.75 mm $337.05 mm +22.6%
WCM Investment Management 5.25 mm $298.97 mm -7.5%
Largest transactions Shares Bought/sold Change
T. Rowe Price 0.00 -21.60 mm EXIT
T. Rowe Price Investment Management 6.35 mm +6.35 mm NEW
Jennison Associates 3.08 mm -3.27 mm -51.5%
BK Bank Of New York Mellon 5.11 mm +2.47 mm +93.2%
Citadel Advisors 2.55 mm +2.08 mm +434.8%
RY Royal Bank Of Canada 2.51 mm +1.46 mm +139.4%
Holocene Advisors 1.09 mm +1.09 mm NEW
Ako Capital 5.75 mm +1.06 mm +22.6%
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 1.57 mm +809.24 k +106.4%
Zurcher Kantonalbank 6.89 mm +791.61 k +13.0%
Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

News

From Benzinga Pro
This Favorable Sign Appears On Alcon's Chart
24 Jan 23
If history is any guide, there may be good fortune ahead for shares of Alcon (NYSE:ALC). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022
22 Dec 22
Mizuho Initiates Coverage On Alcon with Buy Rating, Announces Price Target of $85
22 Dec 22
Mizuho analyst Anthony Petrone initiates coverage on Alcon (NYSE:ALC) with a Buy rating and announces Price Target of $85.
5 Analysts Have This to Say About Alcon
21 Dec 22
BTIG Maintains Buy on Alcon, Raises Price Target to $78
21 Dec 22

Press releases

From Benzinga Pro
Alcon Introduces a Premium, Reusable Toric Lens with Launch of TOTAL30 for Astigmatism
5 Jan 23
The first reusable, Water Gradient lens for astigmatic contact lens wearers Reusable toric market is greater than $1.2B and growing1 Commercially available in the U.S. and Europe beginning in early 2023 Alcon
Alcon to Present at 2023 Annual J.P. Morgan Healthcare Conference
28 Dec 22
Alcon (NYSE:ALC) CEO David Endicott will present at the 2023 J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 11:15 a.m. PST. A live webcast of the conference will be available at
Alcon Prices US$1.3 Billion Senior Notes Offering
29 Nov 22
Alcon Inc. ("Alcon") (NYSE:ALC) announced that it has commenced and priced a private offering of US$700 million aggregate principal amount of its 5.375% senior notes due 2032 and US$600 million aggregate
Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company's Ophthalmic Pharmaceutical Business
22 Nov 22
Thinking about trading options or stock in Target, NVIDIA, Lowe's Companies, NetEase, or Alcon?
16 Nov 22
Finsight
Resources
  • Knowledgebase
  • Log In
  • Register
Company
  • About
  • Contact
  • Solutions
Products
  • Deal Roadshow
  • DealVDR
  • Evercall
  • Finsight.com
CapEdge
  • Earnings Calendar
  • Earnings Transcripts
  • EDGAR Filing Screener
  • IPO Calendar
  • Compliance
  • Privacy
  • Security
  • Terms
AngelList LinkedIn